Soleus Capital Management as of March 31, 2022
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 65 positions in its portfolio as reported in the March 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr Ser Tr S&p Biotech Call Option (XBI) | 16.3 | $127M | 1.4M | 89.88 | |
United Therapeutics Corporation (UTHR) | 7.1 | $55M | 306k | 179.41 | |
Essa Pharma Com New (EPIX) | 3.4 | $26M | 4.2M | 6.18 | |
SurModics (SRDX) | 3.3 | $25M | 558k | 45.33 | |
Edap Tms S A Sponsored Adr (EDAP) | 2.9 | $23M | 3.1M | 7.25 | |
AngioDynamics (ANGO) | 2.9 | $22M | 1.0M | 21.54 | |
Illumina (ILMN) | 2.8 | $22M | 62k | 349.41 | |
OraSure Technologies (OSUR) | 2.7 | $21M | 3.1M | 6.78 | |
Organogenesis Hldgs (ORGO) | 2.5 | $19M | 2.5M | 7.62 | |
Iradimed (IRMD) | 2.5 | $19M | 430k | 44.84 | |
Krystal Biotech (KRYS) | 2.5 | $19M | 289k | 66.54 | |
Neuropace (NPCE) | 2.5 | $19M | 2.3M | 8.21 | |
Theratechnologies | 2.4 | $19M | 7.7M | 2.45 | |
Dice Therapeutics | 2.4 | $19M | 984k | 19.13 | |
Apollo Endosurgery | 2.3 | $18M | 2.9M | 6.05 | |
Hologic (HOLX) | 2.2 | $17M | 226k | 76.82 | |
Iveric Bio | 2.1 | $16M | 965k | 16.83 | |
Evolus (EOLS) | 2.0 | $15M | 1.4M | 11.22 | |
Enanta Pharmaceuticals (ENTA) | 1.9 | $14M | 203k | 71.18 | |
Nurix Therapeutics (NRIX) | 1.8 | $14M | 1.0M | 14.01 | |
Arcellx Common Stock (ACLX) | 1.8 | $14M | 990k | 14.02 | |
Fibrogen (FGEN) | 1.7 | $13M | 1.1M | 12.02 | |
Bioatla (BCAB) | 1.6 | $13M | 2.5M | 5.00 | |
Pieris Pharmaceuticals | 1.6 | $13M | 4.1M | 3.03 | |
Inspire Med Sys (INSP) | 1.6 | $12M | 48k | 256.68 | |
Smith & Nephew Spdn Adr New (SNN) | 1.6 | $12M | 385k | 31.90 | |
Steris Shs Usd (STE) | 1.3 | $10M | 41k | 241.76 | |
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.3 | $9.9M | 178k | 55.31 | |
CVS Caremark Corporation (CVS) | 1.2 | $9.4M | 93k | 101.21 | |
Supernus Pharmaceuticals (SUPN) | 1.0 | $8.1M | 251k | 32.32 | |
10x Genomics Cl A Com (TXG) | 1.0 | $8.1M | 106k | 76.07 | |
Fate Therapeutics (FATE) | 1.0 | $8.0M | 206k | 38.77 | |
Vaxcyte (PCVX) | 1.0 | $7.9M | 328k | 24.15 | |
Mirum Pharmaceuticals (MIRM) | 1.0 | $7.6M | 344k | 22.02 | |
Astrazeneca Sponsored Adr (AZN) | 1.0 | $7.5M | 113k | 66.34 | |
Eiger Biopharmaceuticals | 0.8 | $6.5M | 783k | 8.30 | |
Natera (NTRA) | 0.8 | $6.3M | 155k | 40.68 | |
Dex (DXCM) | 0.8 | $5.9M | 12k | 511.59 | |
Xenon Pharmaceuticals (XENE) | 0.7 | $5.8M | 190k | 30.57 | |
CVRX (CVRX) | 0.7 | $5.8M | 962k | 5.99 | |
Neogenomics Com New (NEO) | 0.7 | $5.6M | 460k | 12.15 | |
Inmode SHS (INMD) | 0.7 | $5.4M | 147k | 36.91 | |
C4 Therapeutics Com Stk (CCCC) | 0.5 | $4.0M | 167k | 24.26 | |
The Beauty Health Company Com Cl A (SKIN) | 0.5 | $3.8M | 228k | 16.88 | |
Sientra | 0.5 | $3.6M | 1.6M | 2.22 | |
Io Biotech (IOBT) | 0.5 | $3.6M | 673k | 5.30 | |
Xilio Therapeutics (XLO) | 0.4 | $3.4M | 478k | 7.07 | |
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.4 | $2.9M | 300k | 9.80 | |
Y Mabs Therapeutics (YMAB) | 0.4 | $2.8M | 239k | 11.88 | |
Immunic (IMUX) | 0.3 | $2.7M | 240k | 11.30 | |
Intuitive Surgical Com New (ISRG) | 0.3 | $2.4M | 7.8k | 301.67 | |
Celldex Therapeutics Com New (CLDX) | 0.3 | $2.4M | 69k | 34.06 | |
Verastem | 0.3 | $2.3M | 1.6M | 1.41 | |
Liquidia Corporation Com New (LQDA) | 0.3 | $2.1M | 294k | 7.18 | |
Cytek Biosciences (CTKB) | 0.3 | $1.9M | 180k | 10.78 | |
Cara Therapeutics (CARA) | 0.2 | $1.9M | 159k | 12.15 | |
Pacira Pharmaceuticals (PCRX) | 0.2 | $1.7M | 22k | 76.31 | |
Pliant Therapeutics (PLRX) | 0.2 | $1.7M | 240k | 7.01 | |
Miragen Therapeutics (VRDN) | 0.2 | $1.7M | 90k | 18.49 | |
Novocure Ord Shs (NVCR) | 0.2 | $1.4M | 17k | 82.84 | |
Crispr Therapeutics Namen Akt (CRSP) | 0.2 | $1.4M | 22k | 62.77 | |
Bridgebio Pharma Note 2.500% 3/1 (Principal) | 0.2 | $1.2M | 2.0M | 0.60 | |
Da32 Life Scnce Tec Acqstn C Class A Com | 0.1 | $972k | 100k | 9.72 | |
Olink Hldg Ab Sponsored Ads (OLK) | 0.1 | $953k | 54k | 17.66 | |
Celcuity (CELC) | 0.0 | $300k | 32k | 9.35 |